Search results
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance UK· 5 days agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance· 4 days agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company...
AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth
Evening Standard· 5 days agoThe top-paid boss on the FTSE 100, AstraZeneca’s Pascal Soriot, bounced back today from the row over...
Angle inks deal with AstraZeneca
ShareCast· 5 days agoLiquid biopsy specialist Angle announced a supplier agreement with AstraZeneca on Wednesday to develop and validate a methodology using Angle's existing...
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via Yahoo Finance UK· 5 days agoAstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by...
Astrazeneca: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance UK· 5 days agoCAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported first-quarter net income of $2.18 billion. The Cambridge, Britain-based company ...
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
EuroNews· 5 days agoPharmaceutical giant AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing...
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
The Irish Times· 5 days agoEurope is “falling behind” the US and China in life sciences innovation, the chief executive of ...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance UK· 7 days agoAstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last...
AstraZeneca blows past analysts' estimates for Q1
ShareCast· 5 days agoAstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug...
